CRP and non-small cell lung carcinoma: Wei et al. conducted a retrospective study and reported the higher survival rate of patients with NSCLC and high CRP levels but low LDH levels after receiving anti-PD-1/PD-L1 treatment, thereby affecting patient prognosis [24].